ARTICLES — REFLECTIONS

SORT date author clear filters


Show


Scadding JG (2002).
Reflections on my studies of the effects of sulphonamide drugs in bacillary dysentery in Egypt, 1943-1944. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Silverman WA† (2003).
Personal reflections on lessons learned from randomized trials involving newborn infants, 1951 to 1967. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Crofton J† (2004).
The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vessey MP (2006).
Learning how to control biases in studies to identify adverse effects of drugs. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jenicek M (2006).
Méta-analyse en médecine: the first book on systematic reviews in medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Grimes DA (2007).
Discovering the need for randomized controlled trials in obstetrics: a personal odyssey. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jick H (2008).
Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Sackett DL† (2008).
A 1955 clinical trial report that changed my career. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stjernswärd J (2009)
Meta-analysis as a manifestation of ‘bondförnuft’ (‘peasant sense’). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Thacker SB† (2009).
How I came to write papers for clinicians in the late 1980s about improving the quality of reviews. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Guyatt GH, Oxman AD (2009).
Medicine’s methodological debt to the social sciences. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Klingberg MA (2010).
An epidemiologist’s journey from typhus to thalidomide, and from the Soviet Union to Seveso. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P (2013).
The evolution of ways of deciding when clinical trials should stop recruiting. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stjernswärd J (2013)
Personal reflections on contributions to pain relief, palliative care and global cancer control JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Sackett DL† (2015).
Why did I become a clinician-trialist? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Haynes RB (2016).
Improving reports of research by more informative abstracts: a personal reflection JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nothing found, please try resetting your search filters